导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -3.31% | 3222/4773 |
| 近一周 | -1.36% | 2068/5465 |
| 近一月 | -6.70% | 4293/5421 |
| 近一季 | 9.88% | 204/5231 |
| 近半年 | -2.58% | 2200/4920 |
| 近一年 | -15.25% | 3717/4394 |
| 近两年 | 17.32% | 2695/2954 |
| 近三年 | -10.64% | 2039/2253 |
| 成立以来 | -8.67% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-1.48% 2318/4961 |
-6.09% 3658/5312 |
- - |
- - |
| 2025 | 5.11% 3012/4813 |
0.77% 1772/3635 |
2.04% 1929/4076 |
16.12% 2715/4524 |
-11.97% 4224/4813 |
| 2024 | -11.75% 2359/3463 |
-10.59% 2356/2808 |
-8.70% 2271/3014 |
18.78% 932/3129 |
-8.98% 2893/3463 |
| 2023 | -10.98% 1358/2656 |
0.18% 1753/2280 |
-7.51% 1857/2385 |
-1.53% 541/2515 |
-2.43% 472/2655 |
| 2022 | -20.90% 999/2207 |
-12.46% 617/1919 |
-0.27% 1611/2016 |
-16.87% 1515/2113 |
9.00% 243/2208 |
| 2021 | -11.44% 1110/1822 |
-3.56% 813/1255 |
13.96% 272/1330 |
-14.97% 1378/1466 |
-5.24% 1507/1822 |
| 2020 | 48.47% 185/1250 |
6.03% 47/1028 |
28.12% 115/1067 |
3.58% 976/1164 |
5.52% 783/1184 |
| 2019 | - - |
- - |
-1.53% 308/788 |
4.89% 175/850 |
4.09% 818/918 |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 万家中证港股通创新药ETF | 1.5896 | 28.31% |
| 港股医疗ETF | 1.4282 | 28.15% |
| 天弘恒生沪深港创新药精选50ETF | 0.8437 | 27.35% |
| 华富中证港股通创新药指数型发起式A | 1.1464 | 27.24% |
| 嘉实中证港股通创新药指数发起式C | 0.8441 | 26.80% |
| 中欧中证港股通创新药指数发起A | 1.5868 | 26.75% |
| 中欧中证港股通创新药指数发起C | 1.4370 | 26.67% |
| 永赢中证港股通医疗主题ETF发起联接A | 0.8762 | 26.58% |
| 华夏中证港股通医疗主题ETF发起式联接A | 0.8585 | 26.45% |
| 华夏中证港股通医疗主题ETF发起式联接C | 0.8568 | 26.39% |
| 汇添富中证医药ETF联接A VS. 长安沪深300非周期A(740101) |